DE60041393D1 - Cytokine aus säugetieren, verwandte reagenzien und verfahren - Google Patents

Cytokine aus säugetieren, verwandte reagenzien und verfahren

Info

Publication number
DE60041393D1
DE60041393D1 DE60041393T DE60041393T DE60041393D1 DE 60041393 D1 DE60041393 D1 DE 60041393D1 DE 60041393 T DE60041393 T DE 60041393T DE 60041393 T DE60041393 T DE 60041393T DE 60041393 D1 DE60041393 D1 DE 60041393D1
Authority
DE
Germany
Prior art keywords
cytokins
mammals
methods
related reagents
reagents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60041393T
Other languages
German (de)
English (en)
Inventor
Birgit Oppmann
Jacqueline C Timans
Robert A Kastelein
J Fernando Bazan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DE60041393D1 publication Critical patent/DE60041393D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60041393T 1999-03-11 2000-03-09 Cytokine aus säugetieren, verwandte reagenzien und verfahren Expired - Lifetime DE60041393D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26790199A 1999-03-11 1999-03-11
PCT/US2000/006182 WO2000053631A1 (en) 1999-03-11 2000-03-09 Mammalian cytokines; related reagents and methods

Publications (1)

Publication Number Publication Date
DE60041393D1 true DE60041393D1 (de) 2009-03-05

Family

ID=23020618

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60041393T Expired - Lifetime DE60041393D1 (de) 1999-03-11 2000-03-09 Cytokine aus säugetieren, verwandte reagenzien und verfahren

Country Status (9)

Country Link
EP (2) EP1159299B1 (enExample)
JP (1) JP2003500010A (enExample)
AR (1) AR022890A1 (enExample)
AT (1) ATE420894T1 (enExample)
AU (1) AU3873200A (enExample)
CA (1) CA2366706A1 (enExample)
DE (1) DE60041393D1 (enExample)
ES (1) ES2319958T3 (enExample)
WO (1) WO2000053631A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2804435A1 (fr) * 2000-01-27 2001-08-03 Pf Medicament COMPLEXE ISOLE COMPRENANT UNE PROTEINE NNT-1 ET EN OUTRE AU MOINS UNE PROTEINE CLF-1 ET/OU UNE PROTEINE sCNTFRalpha
US7045283B2 (en) * 2000-10-18 2006-05-16 The Regents Of The University Of California Methods of high-throughput screening for internalizing antibodies
JP2007515939A (ja) 2003-05-09 2007-06-21 セントカー・インコーポレーテツド ＩＬ−２３ｐ４０特異的免疫グロブリン由来タンパク質、組成物、方法および用途
AR051444A1 (es) 2004-09-24 2007-01-17 Centocor Inc Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos
ES2410406T3 (es) 2005-06-30 2013-07-01 Janssen Biotech, Inc. Anticuerpos anti-IL-23, composiciones, procedimientos y usos
HUE032131T2 (en) 2005-08-31 2017-09-28 Merck Sharp & Dohme Constructed anti-IL-23 antibodies
EP3219328B1 (en) 2005-12-29 2020-06-17 Janssen Biotech, Inc. Human anti-il-23 antibodies, compositions, method and uses
EP2064242A1 (en) 2007-02-23 2009-06-03 Schering Corporation Engineered anti-il-23p19 antibodies
ATE554791T1 (de) 2007-02-23 2012-05-15 Schering Corp Gentechnisch hergestellte anti-il-23p19- antikörper
CA2679381A1 (en) 2007-02-28 2008-09-04 Schering Corporation Engineered anti-il-23r antibodies
AU2008219681A1 (en) 2007-02-28 2008-09-04 Merck Sharp & Dohme Corp. Combination therapy for treatment of immune disorders
WO2014004436A2 (en) 2012-06-27 2014-01-03 Merck Sharp & Dohme Corp. Crystalline anti-human il-23 antibodies
UA117466C2 (uk) 2012-12-13 2018-08-10 Мерк Шарп Енд Доме Корп. СТАБІЛЬНИЙ СКЛАД У ВИГЛЯДІ РОЗЧИНУ АНТИТІЛА ДО IL-23p19
JOP20190260A1 (ar) 2017-05-02 2019-10-31 Merck Sharp & Dohme صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها
WO2018204374A1 (en) 2017-05-02 2018-11-08 Merck Sharp & Dohme Corp. Formulations of anti-lag3 antibodies and co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies
KR20210089215A (ko) 2018-11-07 2021-07-15 머크 샤프 앤드 돔 코포레이션 항-lag3 항체 및 항-pd-1 항체의 공동-제제
AU2019383017A1 (en) 2018-11-20 2021-06-03 Janssen Biotech, Inc. Safe and effective method of treating psoriasis with anti-IL-23 specific antibody
KR20220012883A (ko) 2019-05-23 2022-02-04 얀센 바이오테크 인코포레이티드 Il-23 및 tnf 알파에 대한 항체의 병용요법으로 염증성 장질환을 치료하는 방법
BR112022023489A2 (pt) 2020-05-21 2023-03-14 Janssen Biotech Inc Método de tratamento de doença inflamatória intestinal com uma terapia de combinação de anticorpos para il-23 e tnf-alfa

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
EP0088994B1 (en) 1982-03-15 1991-06-19 Schering Corporation Hybrid dna, binding composition prepared thereby and processes therefor
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5470952A (en) * 1993-10-20 1995-11-28 Regeneron Pharmaceuticals, Inc. CNTF and IL-6 antagonists
DK1243597T3 (da) * 1995-08-01 2008-09-22 Hoffmann La Roche Receptorer for det humane interleukin-12
AUPO224696A0 (en) * 1996-09-11 1996-10-03 Amrad Operations Pty. Limited A novel haemopoietin receptor and genetic sequences encoding same
EP1005552A1 (en) * 1997-01-16 2000-06-07 Genetics Institute, Inc. Member of the hematopoietin receptor superfamily
DE69825580T2 (de) * 1997-02-03 2005-09-29 Amgen Inc., Thousand Oaks Neurotrophischer faktor nnt-1
US5741772A (en) * 1997-02-03 1998-04-21 Amgen Inc. Neurotrophic factor NNT-1
AU7276098A (en) * 1997-05-01 1998-11-24 Zymogenetics Inc. Mammalian cytokine-like receptor
US6046035A (en) * 1997-06-30 2000-04-04 Human Genome Sciences, Inc. Polynucleotides encoding a cardiotrophin-like cytokine
GB9721961D0 (en) * 1997-10-16 1997-12-17 Glaxo Group Ltd Novel molecules
AU736506B2 (en) * 1997-12-03 2001-07-26 Genentech Inc. Polypeptides and nucleic acids encoding the same
AU2454399A (en) * 1998-01-09 1999-07-26 Immunex Corporation H14 dna and polypeptides
AU2661199A (en) * 1998-02-06 1999-08-23 Schering Corporation Mammalian receptor proteins; related reagents and methods
WO2000073451A1 (en) * 1999-06-01 2000-12-07 Schering Corporation Mammalian receptor proteins; related reagents and methods
FR2804435A1 (fr) * 2000-01-27 2001-08-03 Pf Medicament COMPLEXE ISOLE COMPRENANT UNE PROTEINE NNT-1 ET EN OUTRE AU MOINS UNE PROTEINE CLF-1 ET/OU UNE PROTEINE sCNTFRalpha

Also Published As

Publication number Publication date
AU3873200A (en) 2000-09-28
CA2366706A1 (en) 2000-09-14
ATE420894T1 (de) 2009-01-15
EP1159299A1 (en) 2001-12-05
ES2319958T3 (es) 2009-05-18
EP1942114A3 (en) 2008-08-27
AR022890A1 (es) 2002-09-04
JP2003500010A (ja) 2003-01-07
EP1942114A2 (en) 2008-07-09
WO2000053631A1 (en) 2000-09-14
EP1159299B1 (en) 2009-01-14

Similar Documents

Publication Publication Date Title
DE60041393D1 (de) Cytokine aus säugetieren, verwandte reagenzien und verfahren
DE60010594D1 (de) Verfahren und System für Multimediakonferenz
ATA10852001A (de) Bauelement und verfahren zu seiner herstellung
FI982417L (fi) Menetelmä kantajien ominaisuuksien ohjaukseen
ATE418046T1 (de) Allzweckfeuerzeug
NO20023746D0 (no) Optimisert samplesystem
ID28489A (id) Metode untuk membuat 4-karboksiamino-2-disubstitusi 1,2,3,4-tetrahidroquinolin
DE60116076D1 (de) Scherfluidisierende schreibzusammensetzungen, schreibgeräte und verfahren
DE60104073D1 (de) Verfahren zur chromatographischen Trennung
DE69921265D1 (de) Blockcopolymer
DE60126218D1 (de) Verfahren zur herstellung von honigwabenförmigen keramiken vom cordierittyp
DE60107103D1 (de) Bogenzuführvorrichtung und verfahren
DE60213940D1 (de) Proben-Einführungssystem
DE60024535D1 (de) Verfahren zur Zeichentrennung
DE50100782D1 (de) Porosierender, erstarrungsbeschleunigender Bindemittelbaustoff-Zusatz und Verfahren zu seiner Herstellung
DE60120935D1 (de) Kommunikationsschnittstellesystem, verfahren und vorrichtung
DE50007212D1 (de) Verfahren zur isolierung von olefinen aus polyolefinanlagen
DE50001116D1 (de) Verfahren zur justage von parabolantennen
ATE474049T1 (de) Nukleinsäuren aus monocyten und verwandte zusammensetzungen und verfahren
ATE206392T1 (de) Verfahren zur alkylierug von gehinderten sulfonamiden
DE60206470D1 (de) Saw-bauelement und verfahren zu seiner herstellung
DE50103835D1 (de) Sprachsteuerungssystem und verfahren
DE50006598D1 (de) VERFAHREN ZUR HERSTELLUNG VON CYCLO-(Asp-DPhe-NMeVal-Arg-Gly)
FI981272A7 (fi) Homogeeninen biospesifinen määritysmenetelmä
FI981338A0 (fi) Menetelmä multikomponentti-alfa-interferonin valmistamiseksi

Legal Events

Date Code Title Description
8364 No opposition during term of opposition